Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice

Circulation

Volumn 107, Issue 5, 2003, Pages 762-768

  Naghavi, Morteza ^a,b   Wyde, Philip ^c   Litovsky, Silvio ^a,b   Madjid, Mohammad ^a,b   Akhtar, Adeeba ^a,b   Naguib, Sameh ^a,b   Siadaty, Mir Said ^a,b   Sanati, Susan ^a,b   Casscells, Ward ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b TEXAS HEART INSTITUTE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Inflammation; Influenza; Plaque; Thrombosis

Indexed keywords

ACTIN; APOLIPOPROTEIN E;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; INFLAMMATION; INFLUENZA; INFLUENZA VIRUS A; INOCULATION; INTIMA; LD 50; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; THROMBOSIS;

ANIMALS; AORTA, ABDOMINAL; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CELL COUNT; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INFLUENZA A VIRUS; LETHAL DOSE 50; LUNG; LYMPHOCYTES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; ORTHOMYXOVIRIDAE INFECTIONS; PLATELET AGGREGATION; SURVIVAL RATE; THROMBOSIS;

EID: 0037432146     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000048190.68071.2B     Document Type: Article

References (39)

1. Minick CR, Murphy GE, Campbell WG, Jr. Experimental induction of athero-arteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet, I: effect of repeated injections of horse serum in rabbits fed a dietary cholesterol supplement, J Exp Med. 1966;124:635-652.
2. Shah PK. Role of inflammation and metalloproteinases in plaque disruption and thrombosis. Vasc Med. 1998;3:199-206.
3. Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol, 1998;148:937-948.
4. Burch GE, Harb JM, Hiramoto Y, et al. Viral infection of the aorta of man associated with early atherosclerotic changes. Am Heart J. 1973;86:523-534.
5. Fabricant CG, Fabricant J, Litrenta MM, et al. Virus-induced atherosclerosis. J Exp Med. 1978;148:335-340.
6. Epstein SE, Zhu J, Burnett MS, et al. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol. 2000;20:1417-1420.
7. Shah PK. Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither? Circulation 2001;103:5-6.
8. The Eurowinter Group. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet. 1997;349:1341-1346.
9. Meier CR, Jick SS, Derby LE, et al. Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet. 1998;351:1467-1471.
10. Collins S. Excess mortality from causes other than influenza and pneumonia during influenza epidemics. Public Health Rep. 1932;47:2159-2180.
11. Spodick DH, Flessas AP, Johnson MM. Association of acute respiratory symptoms with onset of acute myocardial infarction: prospective investigation of 150 consecutive patients and matched control patients. Am J Cardiol. 1984;53:481-482.
12. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease: a possible trigger for acute myocardial infarction? Int J Epidemiol. 1978; 7:231-239.
13. Abinader EG, Sharif DS, Omary M. Infection wall myocardial infarction preceded by acute exudative pharyngitis in young males. Isr J Med Sci. 1993;29:764-769.
14. Naghavi M, Barlas Z, Siadaty S, et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102:3039-3045.
15. Siscovick DS, Raghunathan TE, Lin D, et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol. 2000; 152:674-677.
16. Lavallee P, Perchaud V, Gautier-Bertrand M, et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke. 2002; 33:513-518.
17. Wilson SZ, Knight V, Wyde PR, et al. Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob Agents Chemother. 1980;17:642-648.
18. Burke AP, Virmani R. Localized vasculitis. Semin Diagn Pathol. 2001; 18:59-66.
19. Johnson JL, Jackson CL. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse, Atherosclerosis. 2001;154:399-406.
20. Calara F, Silvestre M, Casanada F, et al. Spontaneous plaque rapture and secondary thrombosis in apolipoprotein E-deficient and LDL receptordeficient mice. J Pathol. 2001;195:257-263.
21. Rosenfeld ME, Polinsky P, Virmani R, et al. Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse. Arterioscler Thromb Vasc Biol. 2000;20:2587-2592.
22. , Falsey AR, Walsh EE, Francis CW, et al. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis. 2001;183:995-999.
23. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165-2168.
24. Van Lenten BJ, Wagner AC, Nayak DP, et al. High-density lipoprotein loses its anti-inflammatory properties during acute influenza A infection. Circulation. 2001;103:2283-2288.
25. Wyde PR, Couch RB, Mackler BF, et al. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect Immun. 1977; 15:221-229.
26. Luskowitz DT, Lee DM, Schmechel D, et al. Altered immune responses in apolipoprotein E-deficient mice. J Lipid Res. 2000;41:613-620.
27. Julkunen I, Sareneva T, Pirhonen J, et al. Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression. Cytokine Growth Factor Rev. 2001;12:171-180.
28. Libby P, Sukhova G, Lee RT, et al. Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol. 1995;25:S9-S12.
29. Libby P, Simon DI. Inflammation and thrombosis: the clot thickens. Circulation. 2001;103:1718-1720.
30. Tellides G, Tereb DA, Kirkiles-Smith NC, et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature. 2000;403:207-211.
31. Sarawar SR, Doherty PC, Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia. J Virol, 1994;68:3112-3119.
32. Fawaz LM, Sharif-Askari E, Menezes J. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Immunol 1999;163:4473-4480.
33. Houtkamp MA, van Der Wal AC, de Boer OJ, et al. Interleukin-15 expression in atherosclerotic plaques: an alternative pathway for T-cell activation in atherosclerosis? Arterioscler Thromb Vasc Biol. 2001;21:1208-1213.
34. Astry CL, Jakab GJ. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol. 1984;50:287-292.
35. Semkow R, Wilczynski J. Detection and tissue localization of components of the immune complex in animals infected and immunized with influenza virus. Acta Virol. 1979;23:52-58.
36. Quinn MT, Parthasarathy S, Fong LG, et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987;84:2995-2998.
37. Davis LE, Kornfeld M, Daniels RS, et al. Experimental influenza causes a non-permissive viral infection of brain, liver and muscle. J Neurovirol. 2000;6:529-536.
38. Visseren FL, Bouwman JJ, Bouter KP, et al. Procoagulant activity of endothelial cells after infection with respiratory viruses. Thromb Haemost. 2000;84:319-324.
39. Virmani R, Robinowitz M, Atkinson JB, et al. Acquired coronary arterial aneurysms: an autopsy study of 52 patients. Hum Pathol. 1986;17:575-583.